Dr. Benjamin Andreone, PhD

Associate Director, Neuroscience at Atalanta Therapeutics

Speaker

Dr. Benjamin Andreone is currently Associate Director, Neuroscience at Atalanta Therapeutics, where the team is advancing the divalent siRNA (di-siRNA) platform for the treatment of neurological and neurodegenerative disorders. Prior to Atalanta, Benjamin held research roles at Denali Therapeutics and Harvard Medical School to study blood-brain barrier physiology and drug development for Alzheimer’s disease. He earned a Ph.D. in Neuroscience from the Division of Medical Sciences at Harvard University and a B.S. in Biology from University of Maryland.